21
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors

, ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 5973-5993 | Received 06 Jan 2024, Accepted 11 Jun 2024, Published online: 13 Jun 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.